BENNETT TURNER & COLEMAN LLP

Lobbying Income

$720K

Filings

Unique Clients

Active Period

2000–2002

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2002	$200,000	15	14
2001	$280,000	28	18
2000	$240,000	42	19

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
SERONO HOLDING INC	$160,000	4	2000–2001
American Society of Clinical Oncology, Inc.	$80,000	3	2000–2001
ASTRAZENECA	$60,000	4	2000–2002
NOVARTIS PHARMACEUTICALS CORP	$60,000	5	2000–2002
LYMPHOMA RESEARCH FOUNDATION	$40,000	3	2000–2001
ELI LILLY & CO	$40,000	4	2000–2002
JOHNSON & JOHNSON/ORTHO BIOTECH	$40,000	4	2000–2002
BRISTOL MYERS SQUIBB CO	$40,000	4	2000–2002
CELGENE CORP	$40,000	3	2000–2002
PFIZER, INC.	$40,000	3	2000–2002
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA	$20,000	7	2000–2002
LEUKEMIA & LYMPHOMA SOCIETY	$20,000	6	2000–2001
V I TECHNOLOGIES (VITEX)	$20,000	2	2002
CANCER LEADERSHIP COUNCIL	$20,000	4	2000–2002
NORTH AMERICAN BRAIN TUMOR COALITION	$20,000	6	2000–2002
ABBOTT LABORATORIES	$20,000	3	2000–2001
NATL PATIENT ADVOCATE FOUNDATION	$0	3	2000–2001
GLAXOSMITHKLINE CONSUMER HEALTHCARE	$0	5	2000–2002
CYSTIC FIBROSIS FOUNDATION	$0	3	2001
NATL COALITION OF CANCER SURVIVORSHIP	$0	5	2000–2002
CHILDREN'S CAUSE INC	$0	4	2000–2002

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	54
SENATE	54
Health & Human Services, Dept of (HHS)	8
Food & Drug Administration (FDA)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	59
Health Issues	Health Issues	44
Budget/Appropriations	Budget/Appropriations	39
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	32
Copyright/Patent/Trademark	Copyright/Patent/Trademark	1
Pharmacy	Pharmacy	1

BENNETT TURNER & COLEMAN LLP — Lobbying Disclosure | Poliscope